NCT01032850 2021-06-02
Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma
New Mexico Cancer Research Alliance
Phase 2 Terminated
New Mexico Cancer Research Alliance
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center